Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.17 CAD 6.25% Market Closed
Market Cap: 42.1m CAD

Wall Street
Price Targets

TLT Price Targets Summary
Theralase Technologies Inc

Wall Street analysts forecast TLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLT is 0.71 CAD with a low forecast of 0.71 CAD and a high forecast of 0.74 CAD.

Lowest
Price Target
0.71 CAD
316% Upside
Average
Price Target
0.71 CAD
320% Upside
Highest
Price Target
0.74 CAD
332% Upside
Theralase Technologies Inc Competitors:
Price Targets
FEMY
Femasys Inc
815% Upside
ZBH
Zimmer Biomet Holdings Inc
16% Upside
HOLX
Hologic Inc
3% Upside
9996
Peijia Medical Ltd
58% Upside
AHC
Austco Healthcare Ltd
42% Upside
DXCM
Dexcom Inc
33% Upside
1789
AK Medical Holdings Ltd
31% Upside
NNOX
Nano-X Imaging Ltd
197% Upside

Revenue
Forecast

Revenue Estimate
Theralase Technologies Inc

For the last 13 years the compound annual growth rate for Theralase Technologies Inc's revenue is -5%. The projected CAGR for the next 3 years is 227%.

-5%
Past Growth
227%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Theralase Technologies Inc

Operating Income forecast
is not available for
Theralase Technologies Inc

Net Income
Forecast

Net Income Estimate
Theralase Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLT's stock price target?
Price Target
0.71 CAD

According to Wall Street analysts, the average 1-year price target for TLT is 0.71 CAD with a low forecast of 0.71 CAD and a high forecast of 0.74 CAD.

What is Theralase Technologies Inc's Revenue forecast?
Projected CAGR
227%

For the last 13 years the compound annual growth rate for Theralase Technologies Inc's revenue is -5%. The projected CAGR for the next 3 years is 227%.

Back to Top